All News

In a continuing quest to be a one-stop shop to pharmacy professionals and students, Pharmacy Times® has upped its game on the podcast front in 2021 and will continue to introduce more podcasts in 2022.

According to a press release from AbbVie, Vuity is the first and only FDA-approved eye drop to treat this condition, which affects nearly half of the US adult population.

The concentration of C. diff toxins in the stool was linked to how sick patients were at the time of diagnosis and was associated with adverse outcomes, including the risk of infection returning after treatment.

These biomarkers may be able to control inflammation in the body once infected with COVID-19 and can help determine the seriousness of the infection, the researchers noted.

Multiple strategies can be used to create an individualized approach to therapies and removing barriers for patients with cancer.

The study also found that certain E. coli cells in these microenvironments were able to survive phage treatment without acquiring genetic resistance.

Study indicates that women with trauma had greater white matter hyperintensities (WMH) than women without trauma, and the most common trauma associated with WMH was sexual violence.

Rare disease specialty pharmacies offer customizable pharmacy and patient services to make it easier for people living with rare, complex, and often isolating conditions to access the therapy, care, and resources they need.

The past 2 years have been filled with social upheaval, and as trusted community members, pharmacists have stepped up to meet these challenges.

Pembrolizumab (Keytruda) can be used for multiple cancer types, including melanoma, non-small cell lung cancer, and head and neck squamous cell cancer.

Mild dengue fever causes a high fever and flu-like symptoms.

Investigators reviewed 65 analyses published in the Journal of Affective Disorders showing that by mid-2020 signs were comparable to pre-COVID-19 levels.

Asciminib (Scemblix) approved for patients with Philadelphia chromosome–positive chronic myeloid leukemia (CML) in chronic phase who were previously administered 2 or more tyrosine kinase inhibitors.

Kelan Thomas, PharmD, MS, associate professor of clinical sciences at Touro University California College of Pharmacy, on his recent presentations at Insight 2021 and the virtual Sana Symposium on psychedelic adverse effects and drug-drug interactions.

Pfizer and BioNTech have also announced that they will be providing the US government with an additional 50 million of the 10 μg doses, with an expected delivery by April 30, 2022.

How would you answer these patients' questions?

Evidence of a causal relationship between the onset of allergic disease and mental health was limited, suggesting that the observational associations found were due to confounding or other forms of bias.

The investigators said this study is one of the first to measure the impairment and impact of post-acute COVID syndrome on patients.

The study was designed to evaluate elacestrant as a monotherapy compared to the standard of care for the treatment of estrogen receptor-positive/human epidermal growth factor receptor 2 advanced or metastatic breast cancer.

Emily Holcomb, PharmD, BCPS, ISMP Safe Medication Management Fellow, discusses her CPhT 2021 conference presentation regarding targeted medication safety best practices.

Be prepared for this upcoming Halloween with the latest safety and wellness advice from Dr. Sara Hunt, DNP, FNP-C, family nurse practitioner.

As a pharmacist, it’s important to consider the benefits of certification for pharmacy technicians.

Prilosec treats duodenal ulcer and gastric ulcer in adults, treatment of gastroesophageal reflux disease (GERD) in adults and children, and maintenance of healing of erosive esophagitis.

Atogepant is indicated for the preventive treatment of episodic migraine in adults.

Diabetic ketoacidosis develops when the body can't produce enough insulin.

Here are 10 tips for precautions that need to be taken during this fun holiday that are both evergreen and related to COVID-19.

Individuals who are insulin-resistant are 2.66 times more likely to suffer from major depression than those who are not insulin-resistant.

This developing technology offers opportunities for decentralized record-keeping and tracking of transactions, as well as increased overall efficiency and the removal of unnecessary intermediaries.